Image1_Control of Orthodontic Tooth Movement by Nitric Oxide Releasing Nanoparticles in Sprague-Dawley Rats.TIF by Derrick Crawford (12414670)

“…Molar but not incisor tooth movement was inhibited over 50% by injection of the NO releasing nanoparticles. …”

Enhanced cell death in Ku70 KD cells is caspase-dependent. by Mohamed K. Hassan (550762)

“…<p><b><i>A</i></b>. Ku70 KD and control PC-10 cells were treated with hyperthermia (42.5°C) for 6 h in presence or absence of caspase inhibitor (Z-VAD; 50 nM). …”

Proteomic analysis of the response of <i>Trichinella spiralis</i> muscle larvae to exogenous nitric oxide by Xiaoli Wang (46677)

“…Herein, we applied label-free analysis to investigate the effect of sodium nitroprusside (SNP, a NO donor compound) on the proteome of <i>T</i>. …”

<b>Species richness, composition and dominance of core and climate relicts of African Miombo woodlands</b> by Justice Muvengwi (22631075)

“…Species composition difference between sites were evaluated using analysis of similarity (ANOSIM). Our results revealed a pattern where species richness, the Shannon Wiener index, and evenness increased with decreasing relict size. …”

DataSheet_5_BRAFV600E Mutation-Responsive miRNA-222-3p Promotes Metastasis of Papillary Thyroid Cancer Cells via Snail-Induced EMT.zip by Yuan Gao (159945)

“…<p>BRAF mutation accounts for 50% of the PTC (papillary thyroid carcinoma) and is closely associated with high-risk clinicopathological characteristics. …”

Image2_Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms.TIF by Qian Wang (32718)

“…<p>Cholestasis is a clinical syndrome triggered by the accumulation and aggregation of bile acids by subsequent inflammatory responses. …”

Table_5_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)

Image_2_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Image_1_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Table_6_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)

Table_1_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)

Table_8_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)

Table_7_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)

Image_3_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Image_5_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.pdf by Jessica L. Petrick (11413508)

Image_4_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Image_1_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.pdf by Jessica L. Petrick (11413508)

Pancreatic cancer cells and ARG2-expressing CAFs. by Yoshinori Ino (284073)

“…<p>(A) ARG2-expressing CAFs do not support proliferation of pancreatic cancer cells. …”

Supplementary file 1_Therapeutic potential of formononetin in cirrhotic portal hypertension: modulating hepatic fibrosis, macrophage polarization, and lymphangiogenesis.doc by Zhenghao Wu (9732511)

“…</p>Methods<p>In vivo experiments, bile duct ligation (BDL) induced PHT models were conducted in rats, followed by a 4-week FN treatment (50 mg/kg/day) administered via gavage. …”

Image_4_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.pdf by Jessica L. Petrick (11413508)